
June 17, 2026
New Liver Targeted Insulin Shows Promise for Safer Type 1 Diabetes Treatment
UNC School of Medicine researchers announce how a novel insulin approach shows promise for safer, more stable blood sugar management in type 1 diabetes in the OPTI-2 clinical trial.









